Ezra, a medical imaging company that provides cancer screening solutions, raised $18 million in Series A funding. FirstMark Capital, an early-stage venture capital firm, led the financing round.
The New York-based startup plans to use new funds to make its MRI screening program more widely accessible to patients.
Headquartered in New York, the company has research and development (R&D) operations in Toronto; and its cancer screening services are available in New York, San Francisco, and Los Angeles. It also offers preventative prostate cancer screening programs for people to make decisions about their future health.
According to the company’s data, one in three people will be diagnosed with cancer during their lifetime, and over half will discover it late. The company says it is creating AI solutions that assist radiologists in their analysis of MRI scans and equips them with precise information to diagnose cancer disease at an early stage.
“Our mission at Ezra is to help everyone in the world detect cancer early, and give individuals a path to longer, healthier lives through data and preventative care. More than 1.5 million people in the US have been infected with the coronavirus, and many of them may have long-lasting lung damage caused by the virus. The Ezra COVID 360 enables individuals to get a look inside their lungs, empowering them with the data necessary to make better decisions about their health,” said Emi Gal, CEO, and co-founder of Ezra.
New investors Jeff Raider and Dave Gilboa (co-founders of Harry’s and Warby Parker), Vlad Tenev (co-founder of Robinhood), Fred Destin (co-founder of Stride VC), and Andrei Dunca (co-founder & CTO of LiveRail), and existing investors Accomplice, Seedcamp, Credo Ventures, Founders Future, LDV Capital, Esther Dyson, Taavet Hinrikus, Daniel Dines, Dave McClure, and Jeremy Arditi, also participated in the Series A financing round.
According to Mercom Q1 2020 Funding and M&A Report, medical imaging companies raised $80 million in Q1 2020. Recently, Braid Health, an AI-powered diagnostic imaging platform, raised $9 million led by Lux Capital, a healthcare-focused venture capital firm.
Image Credit: Ezra
